Compare MXCT & CHGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MXCT | CHGG |
|---|---|---|
| Founded | 1999 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.0M | 117.4M |
| IPO Year | 2021 | 2013 |
| Metric | MXCT | CHGG |
|---|---|---|
| Price | $1.19 | $1.02 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 1.3M |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 88.15 |
| EPS | N/A | ★ N/A |
| Revenue | $33,026,000.00 | ★ $376,908,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18.50 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.64 | $0.52 |
| 52 Week High | $2.37 | $1.87 |
| Indicator | MXCT | CHGG |
|---|---|---|
| Relative Strength Index (RSI) | 57.63 | 43.43 |
| Support Level | $1.08 | $0.99 |
| Resistance Level | $1.30 | $1.20 |
| Average True Range (ATR) | 0.07 | 0.09 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 46.40 | 9.38 |
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.
Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Chegg Skilling; and Academic Services, which derives maximum revenue. Geographically, it derives in United States and International.